Breakthrough Gene Therapy at Primary Childrenâs Hospital helps little cowboy thrive
A rare, progressive genetic disease thatâs often fatal for infants and toddlers has been stopped its tracks by a groundbreaking gene therapy at Intermountain Primary Childrenâs Hospital.
By: Sponsored Content
and last updated 2021-02-11 10:35:47-05
A rare, progressive genetic disease thatâs often fatal for infants and toddlers has been stopped its tracks by a groundbreaking gene therapy at Intermountain Primary Childrenâs Hospital.
Primary Childrenâs was one of the first in the United States to offer the gene therapy Zolgensma, used to treat spinal muscular atrophy (SMA) in children younger than 2 years.
It has been 30 years since the start of the Hold On To Dear Life campaign started at Intermountain Primary Children s Hospital. This year brought unique challenges and yet the hospital was able to give more than 4,200 free life-saving devices out to the community.
Here are four ways the Hold On To Dear Life program has helped the communities of Utah and Idaho the past three decades, and how injury prevention efforts will continue in the years to come.
30 years of safety
The Hold On To Dear Life campaign started in 1990 at Primary Children s Hospital to educate the community on how to keep children safe. The first campaign focused on the importance of seat belt use and how to properly use child restraints in the car. Then it expanded to include additional injury prevention. In the last few years, it has been broadened to include mental wellness, the award-winning, Spot the Tot program, and other injury prevention topics such as water safety and window falls.
Primary Children's donates 4,200 life-saving devices to Utah, Idaho families kjzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kjzz.com Daily Mail and Mail on Sunday newspapers.